US antivirals specialist Gilead Sciences on Friday announced results from the PURPOSE 5 trial showing significantly higher ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an extension of the marketing authorization ...

US RNA editing company Korro Bio revealed on Friday that it had received written notice from Denmark’s Novo decisions to ...

Cloudbreak Pharma, the Irvine, California-based ophthalmic drug company, said its multi-kinase inhibitor eye drop CBT-001 met ...

Johnson & Johnson said the US Food and Drug Administration (FDA) has granted accelerated approval to Rybrevant Faspro ...

White, chief executive at Combat Medical, a UK based global company dedicated to bringing hyperthermic treatments to patients ...

The US Centers for Medicare & Medicaid Services (CMS) is establishing a permanent framework for negotiating prices of high-cost drugs.

Swiss specialty pharmaceutical company Dipharma has acquired long-time UK partner LogixX Pharma, bringing the commercial ...

For a pharmaceutical company waiting on a US approval decision, the PDUFA date is closely watched. It marks when the US ...

US clinical-stage biotech Evommune and Hinova Pharmaceuticals have entered into an exclusive license agreement granting ...

USA-based mRNA vaccines company Moderna announced that Health Canada has authorized mFLUSIVA (Influenza mRNA vaccine; mRNA-1010) and mCOFLU (Combined Influenza and COVID-19 mRNA vaccine; mRNA-1083) ...

For a generic drug company in the USA, being first is not simply a matter of getting a copy of a medicine through the US ...